ResMed (NYSE:RMD) traded higher in the last at $55.97, gaining 0.5 points or 0.9%. From the data available, it can be said that the stock did not make an impact in the money flow department with the net figure coming to be $(-19.31) million. The composite uptick value of $6.63 million was eclipsed by the accrued downtick value of $25.94 million, thereby ensuring the up/down ratio of 0.26. For the week, the shares have posted returns of 0.9%.A block trade registered during the day has revealed $0 million in upticks and $19.54 million in downticks. The up/down ratio in this case turned out to be 0. The net money flow for the block trade was $(-19.54) million.
The stock has recorded a 20-day Moving Average of 2.63% and the 50-Day Moving Average is 1.98%. ResMed Inc. has lost 0.66% in the last five trading days and dropped 2.49% in the last 4 weeks. ResMed Inc. is up 3.97% in the last 3-month period. Year-to-Date the stock performance stands at 4.8%.
Investors should note that the Company has disclosed insider buying and selling activities to the Securities Exchange, The Securities and Exchange Commission has divulged that Farrell Michael J., officer (Chief Executive Officer) of Resmed Inc, had unloaded 5,975 shares at an average price of $58.57 in a transaction dated on March 15, 2016. The total value of the transaction was worth $349,956. Currently the company Insiders own 2.54% of ResMed shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -13.03% . Institutional Investors own 58.45% of ResMed shares. During last six month period, the net percent change held by insiders has seen a change of -19.03%.
ResMed (NYSE:RMD) rose 0.9% or 0.5 points on Monday and made its way into the gainers of the day. After trading began at $55.72 the stock was seen hitting $56.11 as a peak level and $55.51 as the lowest level. The stock ended up at $55.97. The daily volume was measured at 1,255,233 shares. The 52-week high of the share price is $75.33 and the 52-week low is $48.99. The company has a market cap of $7,838 million.
ResMed Inc. is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB). The Company develops various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. It produces continuous positive airway pressure, variable positive airway pressure and AutoSet systems for the titration and treatment of SDB. Its products also include S9 Escape, AirSense 10 Elite, AirSense 10 CPAP, S9 VPAP S, S9 VPAP ST, S9 VPAP Adapt, S9 VPAP ST-A, S9 VPAP COPD and AirCurve 10 V Auto, among others. It markets sleep recorders for the diagnosis and titration of SDB in sleep clinics and hospitals. Its products include Quattro FX, Swift FX for Her, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Swift FX Nano, AirFit N10 and Apnealink Air.